The University of Kansas Cancer Center is a clinical research site located in Fairway, Kansas, United States 66205.
Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.
The University of Kansas Cancer Center has participated in 11 clinical trials with 5 currently active.
Therapeutic areas: Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia.
Sponsors: Beam Therapeutics Inc., Nexcella Inc., Vor Biopharma.
Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
The University of Kansas Cancer Center has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The University of Kansas Cancer Center has 11 clinical trials on record, with 5 currently active. Their work covers Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia.
Yes — The University of Kansas Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.